OTLK,Outlook Therapeutics, Inc. | Healthcare

Healthcare

OTLK

All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities

Outlook Therapeutics, Inc.OTLK

USD

- At close

USD

- Until the end

The complete list of US stocks

MAX

Overview >

% Change

Description >

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications.

Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases.

Outlook Therapeutics, Inc. has collaboration and license agreements with BioLexis Pte. Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018.

Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.

Latest News >

JPMorgan's profit jumps on dealmaking, trading boost

Apr 11, 2025

April 11 (Reuters) - JPMorgan Chase's ( JPM ) first-quarter profit rose 9% as it earned more from dealmaking and trading. Earnings were $14.6 billion, or $5.07 a share, for the three months ended March 31, the biggest U.S. bank said on Friday. That compares with $13.4 billion, or $4.44 a share, a year earlier. Investment banking fees rose 12%...

JPMorgan's profit jumps on dealmaking, trading boost

Apr 11, 2025

(Reuters) - JPMorgan Chase's ( JPM ) first-quarter profit rose 9%, helped by higher fees from dealmaking and a record performance in equities trading. Investment banking fees rose 12% while equity markets revenue surged 48% to a record of $3.8 billion, as business was largely buoyed by optimism in the first three months of 2025 that U.S. President Donald Trump...

Wells Fargo's Q1 Earnings Rise, Revenue Declines

Apr 11, 2025

06:52 AM EDT, 04/11/2025 (MT Newswires) -- Wells Fargo ( WFC ) reported Q1 earnings Friday of $1.39 per diluted share, up from $1.20 a year earlier. Analysts polled by FactSet expected $1.23. Total revenue for the quarter ended March 31 was $20.15 billion, down from $20.86 billion a year earlier. Analysts surveyed by FactSet expected $20.72 billion. ...

JPMorgan's profit jumps on dealmaking boost

Apr 11, 2025

April 11 (Reuters) - JPMorgan Chase's ( JPM ) first-quarter profit rose as it earned more from dealmaking. Earnings were $14.6 billion, or $5.07 a share, for the three months ended March 31, the biggest U.S. bank said on Friday. That compares with $13.4 billion, or $4.44 a share, a year earlier. (Reporting by Niket Nishant in Bengaluru and Nupur...